Showing results (81-90 of 500) with videos related to
Sort By:
Pageof 50
The Journal of Experimental Medicine|April 1, 1986
Cloned cytotoxic T lymphocytes that recognize an I-A region product in the context of a class I antigenN Shinohara, J A Bluestone, D H SachsSeminars in Immunology|February 7, 2006
Antigen-specific regulatory T cells--ex vivo expansion and therapeutic potentialEmma L Masteller, Qizhi Tang, Jeffrey A BluestoneJournal of Clinical Immunology|August 22, 2008
T regulatory cells in autoimmune diabetes: past challenges, future prospectsJeffrey A Bluestone, Qizhi Tang, Caitlin E SedwickThe Journal of Experimental Medicine|January 8, 2003
Negative regulation of T cell receptor-lipid raft interaction by cytotoxic T lymphocyte-associated antigen 4Shunsuke Chikuma, John B Imboden, Jeffrey A BluestoneThe Journal of Allergy and Clinical Immunology|July 12, 2002
The immune tolerance network: a new paradigm for developing tolerance-inducing therapiesDaniel Rotrosen, Jeff B Matthews, Jeffrey A BluestoneImmunologic Research|February 1, 1997
CD28/B7 regulation of autoimmune diabetesK G Herold, D J Lenschow, J A BluestoneImmunogenetics|January 1, 1990
Polymorphisms and diversity of T-cell receptor-gamma proteins expressed in mouse spleenR Q Cron, J E Coligan, J A BluestoneInternational Journal of Cancer. Supplement = Journal International Du Cancer. Supplement|January 1, 1992
Activation of T cells in vivo using anti-CD3 and staphylococcal enterotoxinsJ A Bluestone, D S Bruce, K A NewellCell Metabolism|December 17, 2019
New Frontiers in the Treatment of Type 1 DiabetesJeremy T Warshauer, Jeffrey A Bluestone, Mark S AndersonAnnual Review of Pathology|December 14, 2016
Engineering Therapeutic T Cells: From Synthetic Biology to Clinical TrialsJonathan H Esensten, Jeffrey A Bluestone, Wendell A LimPageof 50